Cargando…
Major depressive disorder: mechanism-based prescribing for personalized medicine
Individual patients with depression present with unique symptom clusters – before, during, and even after treatment. The prevalence of persistent, unresolved symptoms and their contribution to patient functioning and disease progression emphasize the importance of finding the right treatment choice...
Autores principales: | Saltiel, Philip F, Silvershein, Daniel I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386790/ https://www.ncbi.nlm.nih.gov/pubmed/25848287 http://dx.doi.org/10.2147/NDT.S73261 |
Ejemplares similares
-
PS96. The change of prescribing patterns for inpatients of major depressive disorder
por: Kim, Hyeri, et al.
Publicado: (2016) -
Personalized Medicine Using Neuroimmunological Biomarkers in Depressive Disorders
por: Chi, Suhyuk, et al.
Publicado: (2021) -
Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide?
por: Cosci, Fiammetta, et al.
Publicado: (2021) -
The relevance of personality assessment in estimating the risk of onset and the outcome of major depressive disorder
por: NEMES, BOGDAN, et al.
Publicado: (2016) -
Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives
por: Shin, Cheolmin, et al.
Publicado: (2020)